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ABSTRACT: The present study investigated postoperative mortality (POM), its
predictors and relationship with long-term survival in patients who underwent surgery
for lung cancer.
The 30-day mortality after thoracotomy in 1,830 patients from the Flemish
multicentre hospital-based lung cancer registry was analysed according to patient,
tumour, treatment and hospital characteristics and compared with 5-yr survival figures
for the same patients.
Overall POM was 4.4%. In univariate analysis age, extent of surgery and low
hospital volume were associated with a higher POM. In multiple regression analysis
age, extent of surgery and side of the pneumonectomy proved to be independent
predictors of POM. In patients agedw70 yrs who underwent right-sided pneumon-
ectomy POM was 17.8%.
Overall, mortality was comparable to published series from referral centres. Age and
extent of resection are the main predictors of postoperative mortality in lung-cancer
patients. In the operable elderly patient, age alone does not justify denying the survival
benefit experienced by resection of lung cancer. The high mortality after right-sided
pneumonectomy in elderly patients warrants caution, as the treatment benefit may
become marginal.
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Lung cancer is the leading cause of cancer death in
the Western world. The age standardized mortality
rate for males in the Flemish region of Belgium (popu-
lation 6 million people) is 113?100,000 inhabitants-1.
More than 3,500 cases a year are diagnosed, of which
63% will die within a year [1]. The frequency dis-
tribution of lung cancer is highest in the seventh
decade. Surgical resection is considered to be the
single curative treatment in nonsmall cell lung can-
cer, provided the procedure is radical and complete.
Nevertheless,v50% of patients are alive o5 yrs after
resection.
Unfortunately, some patients die shortly after sur-
gery, despite intensive preoperative assessment. The
fraction of patients dying within 30 days of operating
is defined as the "postoperative mortality" (POM).
The POM associated with lung-cancer surgery has
aroused controversy in the literature, as only the best
surgeons and hospitals are likely to participate in
multicentre studies and report their experience causing
a skew towards better results. Furthermore, since
POM is reported to increase with age and the pro-
portion of elderly lung-cancer patients is currently
increasing, survival benefit might become marginal.
In order to address these issues, the POM of
patients registered in a large regional multicentre
hospital registry of lung-cancer cases was studied and
compared to the survival data of the same population.
Patients and methods
Database
In Flanders, Belgium, a multicentre hospital
registry of newly diagnosed, histologically proven
lung-cancer cases has been in use since March 1, 1990.
Contributors to this registry are mainly pulmonolo-
gists and thoracic surgeons, assisted by a trained
registration nurse. Patients entered in the registry
represent a proper sample of lung cancer as it is
diagnosed and treated in 52 community and university
hospitals throughout the Flemish region.
The layout of the registry has been presented
elsewhere [2]. Briefly, a selection of clinical, histol-
ogical, endoscopic, radiological and staging data are
collected, together with information on first treat-
ment(s). The variables considered are sex, age, World
Health Organization (WHO) Performance Score,
smoking status at diagnosis, histological type, site
and side of the tumour. Data on cardiac comorbidity
and pulmonary function are not collected. In patients
undergoing surgery, information on type and extent of
resection and pathological staging according to the
tumour, node, metastasis (TNM) classification [3] is
available. The number of thoracotomies performed at
a particular centre is used as an index of experience in
thoracic surgery. POM is defined as death from any
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cause within 30 days after resection of lung cancer,
regardless of whether death occurred in or outside the
hospital. Survival data are validated either by the
registering physician, or at the civil registry office.
Statistical analysis
POM was calculated as the fraction of patients
dying over the total number of patients with the same
characteristic. Confidence intervals (95% CI) around
the point estimates are calculated as exact intervals for
binomial proportions [4]. Univariate analysis of con-
tinuous variables was performed using an unpaired
t-test. A Chi-squared test was used to determine the
significance for discrete variables, with appropriate
use of Yate9s correction for small numbers. The
Mantel-Haenzel trend test was used for the evaluation
of ordinal variables. Multivariate analysis was per-
formed using a logistic regression model. Discrete
variables were represented by indicator variables and
their predictive value was assessed with the p-value of
the log likelihood. Only variables significantly impro-
ving the fit of the model (pv0.05) were included in the
final model. Due to statistical interaction between
side and pneumonectomy, right and left pneumonec-
tomy were entered separately in the model. Survival
estimates were calculated according to the Kaplan-
Meier method and compared using the log-rank test.
Patients dying within 1 month of resection were
excluded from the survival analysis.
Results
From January 1990–November 1996, 8,063 patients
with a primary bronchogenic carcinoma were entered
in the registry. Of these, 1,830 (23%) underwent
thoracotomy. In 100 patients (5.5%), no resection was
performed. In all other patients, various procedures
were undertaken to resect the cancerous lesion. The
median age was 64 yrs (SD 8 yrs) and 89% of the
patients were males. Patients undergoing pneumo-
nectomy were significantly younger (64 yrs) than
those undergoing bilobectomy (67 yrs; pv0.01) or
lobectomy (66 yrs; pv0.01). Of the patients under-
going pneumonectomy, 24% were aged o70 yrs,
compared to 29% of those subjected to lobectomy
and 35% of the bilobectomy cases.
Eighty-one patients (4.4%) died within 30 days
of their operation. The POM according to various
patient, tumour, treatment and hospital characteris-
tics is given in table 1. Sex, performance score accord-
ing to the WHO definition and smoking status did not
affect the POM. In the youngest (v60 yrs) patients,
POM was 2.2%, doubling in the seventh decade, and
increasing further with age to 6.7% in the oldest group
(v0.01). Central versus peripheral location of the pri-
mary tumour had no apparent influence and neither
did morphology and postsurgical stage. No POM
was seen following resection of carcinoid tumours.
The most striking difference related to the extent of
resection was that with increasing loss of lung
parenchyma, POM rate rose from 1.5% to 7.2%
(pv0.01). Finally, hospital volume, defined as the
annual number of resections performed per institution
and used as an index of thoracic surgical experience,
had a small influence on POM. The highest POM was
seen in patients subjected to right-sided pneumonect-
omy, in whom it was more than double that of left-
sided pneumonectomy (pv0.01) (table 2). The prog-
nostic effect of tumour side was not seen with lesser
resections. Chest-wall resection and extensive medi-
astinal lymph node dissection were not significantly
associated with a higher POM than uncomplicated
resection.
In multiple regression analysis, age, extent and side
of resection were independently associated with a
higher 30-day mortality (table 3). Compared to the
youngest group, the odds ratio (OR) for patients aged
60–69 yrs was 2.1 and 3.3 for patients aged o70 yrs.
Compared to smaller resections, the OR for bilobect-
omy and left pneumonectomy were both 1.5 and for
right pneumonectomy the OR was 4.2.
After exclusion of postoperative deaths, 5-yrs
survival rates were 33% after pneumonectomy, 50%
after bilobectomy and 54% after lobectomy (pv0.01)
(fig. 1) Long-term survival was similar after right and
left pneumonectomy (p=0.69). Controlling for type of
resection, 5-yr survival was similar for patients aged
60–69 yrs and o70 yrs (p=0.43) but better for those
agedv60 yrs (pv0.01).
Discussion
In this multi-institutional study an overall POM of
4.4% was observed which is comparable to the 3.7%
reported in the landmark article by GINSBERG et al. [5].
Based upon the combined experience of referral
centres of the Lung Cancer Study Group, it was
stated that "pneumonectomies should carry a risk of
less than 7%, lobectomies less than 3%, and lesser
resections less than 2%". More recent studies reported
a much higher POM in community hospitals [6, 7] and
general results may be even worse due to publication
bias. For a meaningful comparison between series,
studies should have a sufficient sample size and a
uniform definition of POM. Also, given the varying
proportions of elderly patients and pneumonectomies
in different centres, it is suggested that results should
be reported by age group and extent of resection
(table 4).
Multivariate analysis showed that age, extent of
resection and side of the pneumonectomy were
independent prognostic factors. The prognostic
influence of age has been confirmed in many reports
but was recently disputed by a "Swiss" study with
standard complication rates but a very low operative
mortality, even in the elderly [8]. This would suggest
that early detection and adequate treatment of
complications can be beneficial. Age itself probably
reflects other prognostic factors such as comorbidity
and cardiovascular and pulmonary function, informa-
tion which was not available in the present study.
FERGUSON and KARRISON [9] identified the carbon
monoxide diffusing capacity of the lung (DL,CO) and
preoperative hypertension as important risk factors.
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The authors failed to establish the prognostic value of
the WHO performance status and a study by KOHMAN
et al. [10] previously showed that, even with a wide
range of biological indicators, it is difficult to
determine prognostic factors. Given the modern
level of postoperative mortality, evaluation of the
intrinsic value of these biological factors will require
very large studies and uniform registration of many
risk factors. At present, however, risk evaluation for
surgery will still be based on a clinical assessment of
cardiopulmonary function and comorbidity rather
than on age alone.
The prognostic value of extent of surgery is widely
known and even in patients with sufficient pulmonary
reserve, (bi)lobectomy is preferred to pneumonect-
omy. As a long-term consequence of pneumonectomy,
pulmonary hypertension and progression of emphy-
sema may occur. Survival may appear to be poorer
after pneumonectomy but this is mainly due to
confounding by stage [9]. Minimal operations such
as wedge and segmental resections are sometimes
performed in patients with limited pulmonary reserve
Table 2. –Postoperative mortality (POM) in special
subgroups
Patients n POM %
Side of surgery
Right pneumonectomy 293 10.6
Left pneumonectomy 355 3.9
Pneumonectomy, side not specified 9 22.2
Type of surgery
Incomplete resection 26 11.5
Chest wall resection 47 4.3
Mediastinal lymph node dissection 88 6.8
Table 3. –Multivariate evaluation of prognostic factors for
postoperative mortality
Odds ratio 95% CI
Age yrs
v60 1
60–69 2.1 1.0–4.4
o70 3.3 1.6–7.0
Type of resection
Right pneumonectomy 4.2 2.4–7.2
Left pneumonectomy 1.5 0.7–2.8
Bilobectomy 1.5 0.6–3.6
Other 1
CI: confidence interval.
Table 1. –Postoperative mortality (POM) for various characteristics in 1,830 patients with lung cancer
Patients n POM % p-value
Gender Male 1625 4.8 0.07
Female 205 2.0
WHO performance score 0 697 3.6 0.14#
1 760 4.6
o2 70 7.1
Unspecified 303 5.3
Smoking status Current 973 4.3 0.40
Exw1 yr 627 5.1
Never 121 1.7
Unspecified 109 4.6
Age yrs v60 459 2.2 0.01#
60–69 876 4.3
o70 495 6.7
Site Central 1038 4.8 0.37
Peripheral 712 3.7
Unspecified 80 6.3
Morphology Squamous cell 1106 5.0 0.13
Adenocarcinoma 363 2.5
Other 361 4.7
Pathological stage I 953 3.8 0.19#
II 256 3.9
III-IV 447 5.4
Unknown 174 6.3
Type of resection Pneumonectomy 657 7.2 v0.01
Bilobectomy 153 4.6
Lobectomy 804 2.5
Segmental/wedge 68 1.5
Exploration 100 4.0
Unspecified 48 4.2
Hospital volume} 1–4 319 6.9 0.05#
5–14 561 4.1
15–34 552 4.0
o35 398 3.5
Total 1830 4.4
WHO: World Health Organization; #: Mantel-Haenszel Chi-squared trend test; }: annual number of resections per institution.
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at the risk of increasing local recurrence rates. Exp-
loratory thoracotomies were previously described as
high-risk operations [11] but this is challenged by the
4% POM in the authors series.
One of the striking findings in this study is the
significant difference in POM between right-sided and
left-sided pneumonectomy. This side-specific differ-
ence is not present for lesser resections and has been
previously reported by several authors. In 1974, Weiss
[12] reported a difference of 20% versus 8% and in
1984 NAGASAKI et al. [13] published a difference of
13% versus 0%. This was again confirmed by WAHI et
al. [14] in 1989, 14% versus 1%, and AU et al. [15], 37%
versus 6%, and the present results of 11% versus 4%
confirm that this is not a spurious finding from
subgroup analysis. Similar findings were also recently
observed after induction chemotherapy [16] and can-
not be fully explained by the larger volume of the
right lung. After right pneumonectomy, pulmonary
pressure may be increased which could explain the
higher rate of dysrhythmias [17] and occasionally this
may even lead to an interatrial shunt through a patent
foramen ovale [18]. A higher frequency of complica-
tions such as bronchopleural fistula and empyema has
also been reported for right-sided operations [19] and
the importance of adequate coverage of the bronchial
stump needs to be stressed. Postpneumonectomy
syndrome with mediastinal shift is diagnosed mainly
after right pneumonectomy but can be prevented by
adequate filling of the hemithorax. Postoperative
pulmonary oedema has been described more fre-
quently after right pneumonectomy but this was
recently questioned [20].
The highest operative risk (17.8%) was observed in
patients aged o70 yrs undergoing pneumonectomy
for right-sided lung cancer. Older reports caution for
surgery when POM equals survival [21]. When pro-
posing a major surgical procedure to a patient, one
always has to consider whether the gain in 5-yr
survival outweighs the potential short-term risk of the
intervention. This is particularly true in elderly
patients who combine a higher operative risk with
shorter life expectancy. However, the 5-yr survival
probability of nonsurgically treated patients with
stage I lung cancer is f10% and the life expectancy
at 70 yrs in Western Europe is still 13 yrs. Considering
the fact that 5-yr survival after pneumonectomy is
reasonable, the present authors agree with most
authors that older age should not be the only reason
to withhold surgical therapy [8, 22]. In a disease like
lung cancer, resection may even be proposed to
octogenarians, although results are contradictory
[23, 24]. Independent of age, patients need to be
informed about the operative risk because, even when
a lobectomy is anticipated, more extensive surgery
may be necessary.
In the near future, lung-cancer surgery will be
characterized by increasing numbers of elderly
patients, requiring, more extensive resections, often
preceded by chemo- and/or radiotherapy. The latter
induction procedures make surgical intervention
technically more difficult, and the likelihood of
exploratory thoracotomy without resection will
increase. Results from two early studies report a
POM of 3–6% [25, 26] but it may be expected that
with increasing use of multimodality treatment,
figures will rise substantially, especially after pneumo-
nectomy [27]. In high-risk patient, additional attention
is needed in the postoperative phase and referral to
larger hospitals may be judicious. Surgical experience,
measured by the number of resections per year, has
been identified as an independent prognostic factor
but the authors results on this point were negative, as
was a recent study from the USA [28]. As high-risk
patients tend to be referred to larger centres, the
volume issue should be evaluated in studies with more
detailed information on comorbidity.
To conclude, the present day postoperative morta-
lity in patients with lung cancer, treated in a commun-
ity setting, is acceptable. However further monitoring
is warranted. The extent of surgical intervention as
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Fig. 1. – Survival for patients with nonsmall cell lung cancer by
type of surgery, excluding postoperative deaths. +: lobectomy;
$: bilobectomy; &: pneumonectomy.
Table 4. –Proposed standards for reporting postoperative mortality (POM) by age group and type of resection
Age yrs
v60 60–69 o70
Right pneumonectomy 4.8 (1.3–11.9) 10.2 (5.7–16.6) 17.8 (9.8–28.5)
Left pneumonectomy 0 (-) 4.1 (1.7–8.3) 8.1 (3.3–16.1)
Bilobectomy 0 (-) 6.9 (2.3–15.3) 3.7 (0.5–12.7)
Lesser resections 2.4 (0.9–5.1) 2.4 (1.3–4.2) 3.9 (2.0–6.9)
Data are presented as POM% (95% confidence interval).
144 POSTOPERATIVE MORTALITY AFTER RIGHT PNEUMONECTOMY
well as the age of the patient are independent
predictors and patients in whom right-sided resection
with optional pneumonectomy is envisaged, should be
carefully selected and instructed about the risk of the
procedure. The authors recommend that such proce-
dures should preferably be carried out in experienced
centres.
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